How Healthcare Companies Can Share Data Safely for Offshore Testing and Development

Learn how Protecto helps healthcare companies safely share PHI for offshore testing and development, ensuring data integrity and HIPAA compliance.
Written by
Amar Kanagaraj
Founder and CEO of Protecto
How Healthcare Companies Can Share Data Safely for Offshore Testing and Development

Table of Contents

Share Article

Sharing healthcare data for offshore testing and development is often necessary for innovation, product development, and operational efficiency in the healthcare industry. However, strict regulations around Protected Health Information (PHI) make this process challenging. Sending sensitive healthcare data outside the U.S. can introduce significant regulatory risks and compliance concerns.

To stay compliant, healthcare companies need solutions that can anonymize data without compromising its usability or accuracy. 

The Limitations of Synthetic Data for Healthcare Testing

Many organizations attempt to bypass these restrictions with synthetic data, hoping it can be a safe stand-in for real patient information. However, synthetic data often lacks crucial aspects of data integrity. Preserving relationships such as age-to-dosage dependencies and maintaining primary and foreign key references is essential in healthcare.

Without these, synthetic data can lead to inaccurate testing, high-risk situations, and a lack of reliability. Such complex integrity requirements create a serious gap for healthcare companies, as they cannot ensure meaningful results with synthetic data alone. 

Interested Read: Leveraging Synthetic Data: Strategic Benefits & Use Cases

Why Traditional Anonymization Tools Fall Short 

Some healthcare organizations turn to traditional in-house or older data anonymization tools to mask sensitive information. However, these solutions often fail to preserve the structure and relationships within healthcare datasets, similar to synthetic data. When anonymization tools break data relationships, schema formats, or key dependencies, the resulting dataset becomes unreliable for testing, analytics, or AI development.

Interested Read: A Comprehensive Guide to HIPAA Compliance in the Age of AI

Protecto: A Solution for Integrity-Preserving Data Masking 

Protecto addresses these challenges by providing advanced data masking and anonymization designed specifically for sensitive healthcare data.

Protecto uses format-preserving, length-preserving, and type-preserving data masking techniques, ensuring that the original data structure remains intact.

With Protecto, healthcare organizations can anonymize PHI while preserving critical aspects such as:

  • Primary-foreign key relationships
  • Clinical dependencies like age-to-dosage ratios
  • Data formats required for testing systems

This enables healthcare teams to safely share anonymized healthcare data for offshore testing and development without compromising compliance or data quality.

Real-World Healthcare Data Masking Success Stories

Many healthcare analytics companies leverage Protecto to create anonymized data for offshore development and testing, saving millions in development costs and significantly improving testing quality. Protecto provided the support this company needed to scale its testing and operations without compromising data security by enabling HIPAA-compliant, secure data sharing. 

Conclusion 

For healthcare organizations facing challenges in safely sharing PHI, Protecto provides a secure and compliance-ready data masking solution.

By preserving data integrity while anonymizing sensitive information, Protecto enables:

  • HIPAA-compliant offshore development
  • secure healthcare data sharing
  • reliable testing environments

If your team is struggling with PHI data sharing restrictions, Protecto can help unlock safe, compliant, and effective offshore data usage.

Frequently Asked Questions

How can healthcare companies share PHI safely with offshore teams?

Healthcare companies can share PHI safely by using data anonymization and masking solutions that remove sensitive identifiers while preserving data integrity.

What is the safest way to use healthcare data for offshore testing?

The safest approach is using format-preserving data masking, which anonymizes patient data while maintaining realistic datasets for testing.

Why is synthetic data not always reliable for healthcare testing?

Synthetic data often fails to preserve relationships between healthcare variables, which can lead to inaccurate testing results.

What is data masking in healthcare?

Data masking replaces sensitive information such as patient identifiers with anonymized values while maintaining the dataset’s structure.

Amar Kanagaraj
Founder and CEO of Protecto
Amar Kanagaraj is the Founder and CEO of Protecto, a company focused on securing enterprise data for LLMs, AI agents, and agentic workflows. He is a second-time entrepreneur with 20+ years of experience across engineering, product, AI, go-to-market, and business leadership. Before Protecto, Amar co-founded FileCloud and helped scale it to over $10M ARR as CMO. Earlier in his career, he worked at Sun Microsystems, Booz & Company, and Microsoft Search & AI. He holds an MBA from Carnegie Mellon University and an MS in Computer Science from Louisiana State University.

Related Articles

Why You Shouldn’t Use LLMs to Generate SQL (Security Risks)

Using LLMs to generate SQL may seem powerful, but it introduces security, cost, and reliability risks. Learn safer architecture patterns for production systems....

Stop Blaming AI for Bad System Design | Fix MCP Security

AI failures aren’t model issues—they’re system design flaws. Learn how to fix MCP security with least privilege, validation layers, and proper architecture....

Why “Block All PII” Is the Wrong Answer: Handling Sensitive Data in MCP Systems

Learn why blocking all PII in MCP systems reduces functionality and how context-aware data handling ensures security without sacrificing utility....